The RNA binding protein Quaking represses host interferon response by downregulating MAVS

References

• Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207:2053–2063.
   PubMed Web of Science ®Google Scholar
• Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem. 2007;282:15319–15323.
   PubMed Web of Science ®Google Scholar
• Chow KT, Gale M Jr., Loo YM. RIG-I and other RNA sensors in antiviral immunity. Annu Rev Immunol. 2018;36:667–694.
   PubMed Web of Science ®Google Scholar
• Loo YM, Fornek J, Crochet N, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol. 2008;82:335–345.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008;205:1601–1610.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–105.
   PubMed Web of Science ®Google Scholar
• Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437:1167–1172.
   PubMed Web of Science ®Google Scholar
• Seth RB, Sun L, Ea CK, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005;122:669–682.
   PubMed Web of Science ®Google Scholar
• Xu LG, Wang YY, Han KJ, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell. 2005;19:727–740.
   PubMed Web of Science ®Google Scholar
• Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005;6:981–988.
   PubMed Web of Science ®Google Scholar
• Honda K, Takaoka A, Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006;25:349–360.
   PubMed Web of Science ®Google Scholar
• Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513–545.
   PubMed Web of Science ®Google Scholar
• Ye C, Yu Z, Xiong Y, et al. STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent beta interferon induction. Faseb J. 2019;33:286–300.
   PubMed Web of Science ®Google Scholar
• Haque N, Ouda R, Chen C, et al. ZFR coordinates crosstalk between RNA decay and transcription in innate immunity. Nat Commun. 2018;9:1145.
   PubMed Web of Science ®Google Scholar
• Herdy B, Karonitsch T, Vladimer GI, et al. The RNA-binding protein HuR/ELAVL1 regulates IFN-beta mRNA abundance and the type I IFN response. Eur J Immunol. 2015;45:1500–1511.
   PubMed Web of Science ®Google Scholar
• Bidet K, Dadlani D, Garcia-Blanco MA. G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog. 2014;10:e1004242.
   PubMed Web of Science ®Google Scholar
• Lumb JH, Li Q, Popov LM, et al. DDX6 represses aberrant activation of interferon-stimulated genes. Cell Rep. 2017;20:819–831.
   PubMed Web of Science ®Google Scholar
• Dixit U, Pandey AK, Mishra P, et al. Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells. Nucleic Acids Res. 2016;44:5271–5287.
   PubMed Web of Science ®Google Scholar
• Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481–485.
   PubMed Web of Science ®Google Scholar
• Ebersole TA, Chen Q, Justice MJ, et al. The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet. 1996;12:260–265.
   PubMed Web of Science ®Google Scholar
• Kondo T, Furuta T, Mitsunaga K, et al. Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome. 1999;10:662–669.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhou L, Tonissen K, et al. The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. J Biol Chem. 1999;274:29202–29210.
   PubMed Web of Science ®Google Scholar
• Pilotte J, Larocque D, Richard S. Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. Genes Dev. 2001;15:845–858.
   PubMed Web of Science ®Google Scholar
• Darbelli L, Richard S. Emerging functions of the Quaking RNA-binding proteins and link to human diseases. Wiley Int Rev RNA. 2016;7:399–412.
   Google Scholar
• Hall MP, Nagel RJ, Fagg WS, et al. Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA. 2013;19:627–638.
   PubMed Web of Science ®Google Scholar
• Fagg WS, Liu N, Fair JH, et al. Autogenous cross-regulation of Quaking mRNA processing and translation balances Quaking functions in splicing and translation. Genes Dev. 2017;31:1894–1909.
   PubMed Web of Science ®Google Scholar
• Hayakawa-Yano Y, Suyama S, Nogami M, et al. An RNA-binding protein, Qki5, regulates embryonic neural stem cells through pre-mRNA processing in cell adhesion signaling. Genes Dev. 2017;31:1910–1925.
   PubMed Web of Science ®Google Scholar
• Li J, Choi PS, Chaffer CL, et al. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer. Elife. 2018;7. pii: e37184.
   Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125–1134.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Garg A, Bar C, et al. Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression. Circ Res. 2018;122:246–254.
   PubMed Web of Science ®Google Scholar
• Larocque D, Galarneau A, Liu HN, et al. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci. 2005;8:27–33.
   PubMed Web of Science ®Google Scholar
• Thangaraj MP, Furber KL, Gan JK, et al. RNA-binding protein Quaking stabilizes Sirt2 mRNA during oligodendroglial differentiation. J Biol Chem. 2017;292:5166–5182.
   PubMed Web of Science ®Google Scholar
• Chen AJ, Paik JH, Zhang H, et al. STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA. Genes Dev. 2012;26:1459–1472.
   PubMed Web of Science ®Google Scholar
• Wang Y, Vogel G, Yu Z, et al. The QKI-5 and QKI-6 RNA binding proteins regulate the expression of microRNA 7 in glial cells. Mol Cell Biol. 2013;33:1233–1243.
   PubMed Web of Science ®Google Scholar
• Wang F, Song W, Zhao H, et al. The RNA-binding protein QKI5 regulates primary miR-124–1 processing via a distal RNA motif during erythropoiesis. Cell Res. 2017;27:416–439.
   PubMed Web of Science ®Google Scholar
• Galarneau A, Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol. 2005;12:691–698.
   PubMed Web of Science ®Google Scholar
• de Bruin RG, Shiue L, Prins J, et al. Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression. Nat Commun. 2016;7:10846.
   PubMed Web of Science ®Google Scholar
• Yang G, Fu H, Zhang J, et al. RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology. 2010;138(231–40):e1–5.
   Google Scholar
• Zong FY, Fu X, Wei WJ, et al. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet. 2014;10:e1004289.
   PubMed Web of Science ®Google Scholar
• de Miguel FJ, Pajares MJ, Martinez-Terroba E, et al. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer. Mol Oncol. 2016;10:1437–1449.
   PubMed Web of Science ®Google Scholar
• Li F, Yi P, Pi J, et al. QKI5-mediated alternative splicing of the histone variant macroH2A1 regulates gastric carcinogenesis. Oncotarget. 2016;7:32821–32834.
   PubMedGoogle Scholar
• Sanchez-Quiles V, Mora MI, Segura V, et al. HSV-1 Cgal+ infection promotes quaking RNA binding protein production and induces nuclear-cytoplasmic shuttling of quaking I-5 isoform in human hepatoma cells. Mol Cell Proteomics. 2011;10:M111 009126.
   PubMed Web of Science ®Google Scholar
• Ramanathan M, Majzoub K, Rao DS, et al. RNA-protein interaction detection in living cells. Nat Methods. 2018;15(3):207-212
   Web of Science ®Google Scholar
• Liao KC, Chuo V, Ng WC, et al. Identification and characterization of host proteins bound to dengue virus 3ʹ UTR reveal an antiviral role for quaking proteins. RNA. 2018;24:803–814.
   PubMed Web of Science ®Google Scholar
• Li K, Chen Z, Kato N, et al. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005;280:16739–16747.
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005;175:2851–2858.
   PubMed Web of Science ®Google Scholar
• Kim TK, Maniatis T. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. Mol Cell. 1997;1:119–129.
   PubMed Web of Science ®Google Scholar
• Grandvaux N, Servant MJ, tenOever B, et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol. 2002;76:5532–5539.
   PubMed Web of Science ®Google Scholar
• Osterlund PI, Pietila TE, Veckman V, et al. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol. 2007;179:3434–3442.
   PubMed Web of Science ®Google Scholar
• Lee HC, Narayanan S, Park SJ, et al. Transcriptional regulation of IFN-lambda genes in hepatitis C virus-infected hepatocytes via IRF-3.IRF-7.NF-kappaB complex. J Biol Chem. 2014;289:5310–5319.
   PubMed Web of Science ®Google Scholar
• Wathelet MG, Lin CH, Parekh BS, et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell. 1998;1:507–518.
   PubMed Web of Science ®Google Scholar
• Xu L, Peng L, Gu T, et al. The 3ʹUTR of human MAVS mRNA contains multiple regulatory elements for the control of protein expression and subcellular localization. Biochim Biophys Acta Gene Regul Mech. 2019;1862:47–57.
   PubMed Web of Science ®Google Scholar
• Liu B, Gao C. Regulation of MAVS activation through post-translational modifications. Curr Opin Immunol. 2018;50:75–81.
   PubMed Web of Science ®Google Scholar
• Peisley A, Wu B, Yao H, et al. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell. 2013;51:573–583.
   PubMed Web of Science ®Google Scholar
• Saito T, Hirai R, Loo YM, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2007;104:582–587.
   PubMed Web of Science ®Google Scholar
• Ogilvie RL, Sternjohn JR, Rattenbacher B, et al. Tristetraprolin mediates interferon-gamma mRNA decay. J Biol Chem. 2009;284:11216–11223.
   PubMed Web of Science ®Google Scholar
• Schmidtke L, Schrick K, Saurin S, et al. The KH-type splicing regulatory protein (KSRP) regulates type III interferon expression post-transcriptionally. Biochem J. 2019;476:333–352.
   PubMed Web of Science ®Google Scholar
• Witteveldt J, Ivens A, Macias S. Inhibition of microprocessor function during the activation of the type I interferon response. Cell Rep. 2018;23:3275–3285.
   PubMed Web of Science ®Google Scholar
• Suthar MS, Ma DY, Thomas S, et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 2010;6:e1000757.
   PubMed Web of Science ®Google Scholar
• Rivera-Serrano EE, DeAngelis N, Sherry B. Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-beta expression in cardiac myocytes. J Mol Cell Cardiol. 2017;111:102–113.
   PubMed Web of Science ®Google Scholar
• Wan S, Ashraf U, Ye J, et al. MicroRNA-22 negatively regulates poly(I:C)-triggered type I interferon and inflammatory cytokine production via targeting mitochondrial antiviral signaling protein (MAVS). Oncotarget. 2016;7:76667–76683.
   PubMedGoogle Scholar
• Hsu AC, Dua K, Starkey MR, et al. MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD. JCI Insight. 2017;2:e90443.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149:515–524.
   PubMed Web of Science ®Google Scholar
• Tili E, Chiabai M, Palmieri D, et al. Quaking and miR-155 interactions in inflammation and leukemogenesis. Oncotarget. 2015;6:24599–24610.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhai DS, Ruan BJ, et al. Quaking deficiency amplifies inflammation in experimental endotoxemia via the aryl hydrocarbon receptor/signal transducer and activator of transcription 1-NF-kappaB pathway. Front Immunol. 2017;8:1754.
   PubMed Web of Science ®Google Scholar
• Jiang L, Saetre P, Radomska KJ, et al. QKI-7 regulates expression of interferon-related genes in human astrocyte glioma cells. PLoS One. 2010;5. pii: e13079.
   Web of Science ®Google Scholar
• Karpova AY, Ronco LV, Howley PM. Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3. Mol Cell Biol. 2001;21:4169–4176.
   PubMed Web of Science ®Google Scholar
• Marozin S, Altomonte J, Stadler F, et al. Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3. Mol Ther. 2008;16:1789–1797.
   PubMed Web of Science ®Google Scholar
• Li C, Ma L, Chen X. Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3. Cell Mol Immunol. 2011;8:67–74.
   PubMed Web of Science ®Google Scholar
• Pillman KA, Phillips CA, Roslan S, et al. miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. Embo J. 2018;37(13). pii: e99016.
   PubMed Web of Science ®Google Scholar
• Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281–2308.
   PubMed Web of Science ®Google Scholar
• Bender S, Reuter A, Eberle F, et al. Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus. PLoS Pathog. 2015;11:e1005264.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675.
   PubMed Web of Science ®Google Scholar